Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

ItalyBack to Italy

Clinical trials in Frosinone

7 clinical trials in Frosinone, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Frosinone at a glance
7
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

7 trials in Frosinone

Open in trial search

Cardiovascular disorder+1

Recruiting

Study of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Zilebesiran
  • Sponsor:Alnylam Pharmaceuticals Inc.

Acute myeloid leukaemia

Recruiting

Study of gemtuzumab ozogamicin with chemotherapy for adults aged 18-60 with newly diagnosed favorable-intermediate-risk acute myeloid leukemia

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Busulfan
  • Sponsor:Fondazione Gimema Franco Mandelli Onlus

Skin ulcer

Not recruiting

Study on the Effectiveness of Allo-APZ2-CVU for Patients with Long-Term, Non-Healing Venous Leg Ulcers

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Allogeneic skin-derived ABCB5-POSITIVE dermal mesenchymal stromal cells
  • Sponsor:Rheacell GmbH & Co. KG

Breast cancer

Not recruiting

Study on Chemotherapy and Aromatase Inhibitors (Exemestane, Letrozole, Anastrozole) for Post-Menopausal Patients with Early Breast Cancer

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:IRCCS Ospedale Policlinico San Martino

Colorectal cancer metastatic

Not recruiting

Study Comparing Panitumumab and Regorafenib Sequence for Patients with Metastatic Colorectal Cancer Resistant to Previous Treatments

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Panitumumab
  • Sponsor:Fondazione GONO G.I.

Philadelphia positive acute lymphocytic leukaemia

Not recruiting

Study on Ponatinib and Blinatumomab for Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Blinatumomab
  • Sponsor:Fondazione Gimema Franco Mandelli Onlus

Lung disorder

Not recruiting

Study on Baricitinib for Hospitalized Patients with Severe or Critical COVID-19

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Baricitinib
  • Sponsor:Oslo University Hospital HF

Other cities in Italy

The busiest research cities in the country

All 237 cities in Italy

Clinical research in Frosinone

What the registry says about research in the country

01 Hematologic Oncology

Groundbreaking research focusing on Acute Myeloid Leukemia (AML) treatment strategies, combining novel therapies with standard chemotherapy to improve patient outcomes.

  • AML treatment optimization
  • Minimal residual disease evaluation
  • Combined therapy approaches

Studies include innovative combinations of venetoclax and decitabine for patients unsuitable for intensive chemotherapy.

02 Breast Cancer Research

Advanced studies in endocrine-responsive breast cancer examining optimal treatment timing and combinations for post-menopausal patients.

  • Adjuvant therapy optimization
  • Sequential vs concurrent treatment
  • Endocrine therapy integration

Research focuses on improving treatment sequences with chemotherapy and aromatase inhibitors.

03 Innovative Cancer Therapies

Cutting-edge research in Philadelphia Chromosome-Positive ALL and metastatic colorectal cancer, exploring targeted therapies and antibody treatments.

  • Targeted molecular therapies
  • Chemo-free treatment strategies
  • Sequential treatment approaches

Studies include novel combinations of ponatinib and blinatumomab for leukemia treatment.

04 Infectious Disease Research

Critical studies on COVID-19 through the European DisCoVeRy platform, investigating therapeutic interventions for varying disease severities.

  • Pandemic response trials
  • Treatment protocols for severe cases
  • Immunocompromised patient care

Research includes evaluation of baricitinib in combination with standard care for severe cases.

Back to ItalyAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.